To the best of our knowledge, only Haykowsky et al. [23] have investigated the effects of physical exercise on myocardial function in patients with HER2 positive breast cancer, and they showed that adjuvant trastuzumab therapy is associated with left ventricular (LV) dilation and a reduction in LVEF despite aerobic exercise training. The gene discussed is ERBB2; the disease is breast cancer.